Silver Rock Financial’s Cartesian Therapeutics RNAC Stock Holding History

Silver Rock Financial’s Portfolio RNAC Stock Details RNAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-15,262	Closed	-$1.09M	–	21
2019 Q4	$1.09M	Hold	15,262	–	–	1.35%	16
2019 Q3	$801K	Hold	15,262	–	–	0.81%	17
2019 Q2	$820K	Hold	15,262	–	–	0.84%	19
2019 Q1	$1.08M	Hold	15,262	–	–	0.91%	21
2018 Q4	$1.21M	Sell	15,262 -10,971	-42%	-$2.5M	0.98%	22
2018 Q3	$12.2M	Hold	26,233	–	–	4.44%	10
2018 Q2	$10.4M	Buy	26,233 +1,397	+6%	+$496K	3.22%	18
2018 Q1	$7.58M	Buy	24,836 +2,268	+10%	+$646K	2.71%	18
2017 Q4	$6.64M	Hold	22,568	–	–	3.26%	13
2017 Q3	$12.4M	Hold	22,568	–	–	6.57%	6
2017 Q2	$13.4M	Hold	22,568	–	–	5.36%	8
2017 Q1	$9.68M	Buy	22,568 +7,199	+47%	+$3.03M	4.56%	11
2016 Q4	$7.91M	Buy	+15,369	New	+$8.98M	5.4%	9

Other funds holding RNAC

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return